Back to search

Article

Tibetan umbilical cord mesenchymal stem cell exosomes improve hypoxic pulmonary hypertension by inhibiting pulmonary vascular remodeling

2023-08-04

Abstract excerpt

<h4>Aims: </h4> Pulmonary hypertension (PH) is a progressive disease that involves pulmonary vasoconstriction, pulmonary vascular remodeling, and right ventricular hypertrophy, ultimately leading to right heart failure. However, current treatments for pulmonary hypertension have several limitations. This study aims to explore the therapeutic potential of Tibetan umbilical cord mesenchymal stem cell (MSC) exosomes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5ff5967b-151d-537a-86b9-e61dd7711a1e
DOI
10.21203/rs.3.rs-3209554/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tibetan umbilical cord mesenchymal stem cell exosomes improve hypoxic pulmonary hypertension by inhibiting pulmonary vascular remodelingDOI 10.21203/rs.3.rs-3209554/v1
LncRNAH19 acts as a ceRNA of let-7g to facilitate EndMT in hypoxic pulmonary hypertension via regulating TGF-β signalling pathwaySemantic proximity
Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expressionSemantic proximity
Exosomes derived from hypoxic alveolar epithelial cells promote the phenotypic transformation of pulmonary artery smooth muscle cells via the Rap1 pathway.Semantic proximity
Overexpressed lncRNA AC068039.4 contributes to proliferation and cell cycle progression of pulmonary artery smooth muscle cells via sponging miR-26a-5p/TRPC6 in hypoxic pulmonary arterial hypertensionSemantic proximity
Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension through TGF-β1-Smad2/3 pathwaySemantic proximity
Exosomal miR-17-5p from human embryonic stem cells prevents pulmonary fibrosis by targeting thrombospondin-2Semantic proximity
RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis <i>via</i> LOXL2 Mediated MechanismSemantic proximity
Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndromeSemantic proximity
iPSC modeling of pulmonary arterial hypertension to uncover pathomechanisms and unrecognized modes of action of sotaterceptSemantic proximity
Sotatercept Reverses SIN3a Deficiency-Driven PAH by Reprogramming BMPR2/TGF-β-HIF-1α Signaling PathwaysSemantic proximity
Polygonum cuspidatum Exosome-Like Nanovesicles Alleviate Hypoxic Pulmonary Hypertension by Stabilizing PON1 to Inhibit MAPK-Mediated PASMC Phenotypic Switching.Semantic proximity
Stem cell‐based therapies for cardiac diseases: The critical role of angiogenic exosomesSemantic proximity
Select a neighboring publication to make it the new centre.